228 related articles for article (PubMed ID: 18177929)
1. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
Park JY; Lee KH; Dong SM; Kang S; Park SY; Seo SS
Gynecol Oncol; 2008 Mar; 108(3):549-54. PubMed ID: 18177929
[TBL] [Abstract][Full Text] [Related]
2. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
3. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
4. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract][Full Text] [Related]
5. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
[TBL] [Abstract][Full Text] [Related]
7. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
Song SH; Park HM; Eom DW; Lee JK; Lee NW; Kim AR; Hur JY; Lee KW; Park YK; Saw HS
Int J Gynecol Cancer; 2007; 17(4):858-67. PubMed ID: 17367326
[TBL] [Abstract][Full Text] [Related]
8. Persistent HPV infection after conization in patients with negative margins.
Song SH; Lee JK; Oh MJ; Hur JY; Na JY; Park YK; Saw HS
Gynecol Oncol; 2006 Jun; 101(3):418-22. PubMed ID: 16386782
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for human papillomavirus persistence among women undergoing cold-knife conization for treatment of high-grade cervical intraepithelial neoplasia.
Baser E; Ozgu E; Erkilinc S; Togrul C; Caglar M; Gungor T
Int J Gynaecol Obstet; 2014 Jun; 125(3):275-8. PubMed ID: 24726620
[TBL] [Abstract][Full Text] [Related]
10. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
11. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization.
Chao A; Lin CT; Hsueh S; Chou HH; Chang TC; Chen MY; Lai CH
Am J Obstet Gynecol; 2004 Apr; 190(4):1046-51. PubMed ID: 15118639
[TBL] [Abstract][Full Text] [Related]
13. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
[TBL] [Abstract][Full Text] [Related]
15. Persistence and reappearance of high-risk human papillomavirus after conization.
Gosvig CF; Huusom LD; Andersen KK; Iftner A; Cederkvist L; Svare E; Iftner T; Kjaer SK
Gynecol Oncol; 2013 Dec; 131(3):661-6. PubMed ID: 24035849
[TBL] [Abstract][Full Text] [Related]
16. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
17. Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.
Chang H; Hong JH; Lee JK; Cho HW; Ouh YT; Min KJ; So KA
J Gynecol Oncol; 2018 May; 29(3):e27. PubMed ID: 29400020
[TBL] [Abstract][Full Text] [Related]
18. [Correlations of high-risk human papillomaviral load to cervical intraepithelial neoplasia grades, expression of Ki-67 and P6ink4a and follow-up].
Yi W; Wang JL; Li XH; Wei LH
Ai Zheng; 2008 May; 27(5):520-4. PubMed ID: 18479603
[TBL] [Abstract][Full Text] [Related]
19. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.
Kim YT; Lee JM; Hur SY; Cho CH; Kim YT; Kim SC; Kang SB
Int J Cancer; 2010 Apr; 126(8):1903-1909. PubMed ID: 19642095
[TBL] [Abstract][Full Text] [Related]
20. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
